Lincoln Pharmaceuticals Ltd.
-
NSE: LINCOLN
-
BSE: 531633
-
Q
-
V
-
T
Quality Score
High Financial StrengthValuation Score
Affordable ValuationTechnical Score
Technically NeutralTTM PE Ratio
10.50
Below industry Median
Price to Book Ratio
1.50
Below industry Median
Operating Revenues Qtr Cr
112.50 Cr
Above industry Median
Net Profit Qtr Cr
12.60 Cr
Above industry Median
RSI
44.30
RSI is mid-range
MFI
48.70
MFI is mid-range
MACD
-0.60
MACD below Signal and Center
MACD Signal Line
5.70
MACD below Signal and Center
30Day SMA Rs
399.00 Rs
Price below SMA-30
50Day SMA Rs
384.90 Rs
Price below SMA-50
100Day SMA Rs
359.50 Rs
Price above SMA 359.47
200Day SMA Rs
334.50 Rs
Price above SMA 334.47
Promoter holding %
47.00
Promoter holding increased by 0.6600%.
FII holding current Qtr %
1.27
FII holdings fell by 0.17%
MF holding current Qtr %
0.00
MF holding at 0.00%
Institutions holding %
1.27
Institutions holding decreased by 0.1700%.
Broker Covering stock
0.00
0 Broker Covering stock
Broker 1Year total
0.00
0 Broker 1Year total
Broker 6M Reco downgrade
0.00
0 Broker 6M Reco downgrade
Broker 6M Reco upgrade
0.00
0 Broker 6M Reco upgrade
Broker 6M Target downgrade
0.00
0 Broker 6M Target downgrade
Broker 6M Target upgrade
0.00
0 Broker 6M Target upgrade
Momentum score
50.49
Technically Neutral
Valuation score
54.00
Affordable Valuation
Quality score
64.33
High Financial Strength
Peer Comparison
Stock Name | 30 Day SMA Rs | 50 Day SMA Rs | 100 Day SMA Rs | 200 Day SMA Rs |
---|---|---|---|---|
Lincoln Pharmaceuticals Ltd. | 398.99 | 384.86 | 359.47 | 334.47 |
Sun Pharmaceutical Industries Ltd. | 961.68 | 972.32 | 986.51 | 975.5 |
Divi's Laboratories Ltd. | 3312.65 | 3162.28 | 3111.31 | 3320.57 |
Cipla Ltd. | 929.43 | 914.58 | 956.15 | 1024.82 |
Dr. Reddy's Laboratories Ltd. | 4683.65 | 4667.26 | 4525.71 | 4429.92 |
Torrent Pharmaceuticals Ltd. | 1667.27 | 1621.68 | 1576.26 | 1578.44 |
Mankind Pharma Ltd. | ||||
Zydus Lifesciences Ltd. | 513.93 | 505.21 | 480.66 | 441.36 |